- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x 9MF: methyl N-[4-[(4-fluorophenyl)methyl-prop-2-ynyl-amino]-2,6-dimethyl-phenyl]carbamate(Non-covalent)
- 4 x PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate(Non-covalent)
PIO.2: 14 residues within 4Å:- Chain A: R.25, F.31, F.38, M.146, M.149, D.150, R.152, T.155, K.265
- Chain B: S.167, K.168, V.171, W.174, Y.175
13 PLIP interactions:8 interactions with chain A, 5 interactions with chain B- Hydrophobic interactions: A:F.31, A:F.38, A:M.149, A:T.155, B:V.171, B:W.174, B:Y.175
- Hydrogen bonds: A:R.152, A:R.152
- Salt bridges: A:R.25, A:K.265, B:K.168, B:K.168
PIO.4: 14 residues within 4Å:- Chain B: R.25, F.31, F.38, M.146, M.149, D.150, R.152, T.155, K.265
- Chain D: S.167, K.168, V.171, W.174, Y.175
11 PLIP interactions:8 interactions with chain B, 3 interactions with chain D- Hydrophobic interactions: B:F.31, B:F.38, B:M.149, B:T.155, D:W.174, D:Y.175
- Hydrogen bonds: B:R.152, B:R.152
- Salt bridges: B:R.25, B:K.265, D:K.168
PIO.6: 14 residues within 4Å:- Chain D: R.25, F.31, F.38, M.146, M.149, D.150, R.152, T.155, K.265
- Chain F: S.167, K.168, V.171, W.174, Y.175
12 PLIP interactions:4 interactions with chain F, 8 interactions with chain D- Hydrophobic interactions: F:V.171, F:W.174, D:F.31, D:F.38, D:M.149, D:T.155
- Salt bridges: F:K.168, F:K.168, D:R.25, D:K.265
- Hydrogen bonds: D:R.152, D:R.152
PIO.8: 14 residues within 4Å:- Chain A: S.167, K.168, V.171, W.174, Y.175
- Chain F: R.25, F.31, F.38, M.146, M.149, D.150, R.152, T.155, K.265
13 PLIP interactions:8 interactions with chain F, 5 interactions with chain A- Hydrophobic interactions: F:F.31, F:F.38, F:M.149, F:T.155, A:V.171, A:W.174, A:Y.175
- Hydrogen bonds: F:R.152, F:R.152
- Salt bridges: F:R.25, F:K.265, A:K.168, A:K.168
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ma, D. et al., Ligand activation mechanisms of human KCNQ2 channel. Nat Commun (2023)
- Release Date
- 2023-12-13
- Peptides
- Potassium voltage-gated channel subfamily KQT member 2: ABDF
Calmodulin-1: CEGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BD
DF
GC
CE
FG
HH
E - Membrane
-
We predict this structure to be a membrane protein.
SMTL ID : 8w4u.1
human KCNQ2-CaM in complex with PIP2 and HN37
Potassium voltage-gated channel subfamily KQT member 2
Toggle Identical (ABDF)Calmodulin-1
Toggle Identical (CEGH)Related Entries With Identical Sequence
1iq5.1 | 1lvc.1 | 1lvc.2 | 1lvc.3 | 1wrz.1 | 2bki.1 | 2r28.1 | 2v01.1 | 2v02.1 | 2w73.1 | 2w73.2 | 2y4v.1 | 3hr4.1 | 3hr4.2 | 3hr4.3 | 3hr4.4 | 3j41.1 | 3oxq.1 | 3oxq.2 | 3sjq.1 | 3sui.1 | 4bw7.1 | 4bw7.2 | 4bw7.3 | 4bw8.1 | 4bw8.2 | 4byf.1 | 4byf.2 | 4dck.1 | 4dck.2 more...less...4g27.1 | 4g28.1 | 4j9y.1 | 4j9z.1 | 4jpz.1 | 4jpz.2 | 4jq0.1 | 4l79.1 | 4ovn.1 | 4ovn.2 | 4ovn.3 | 4ovn.4 | 4ovn.5 | 4q5u.1 | 4umo.1 | 4v0c.1 | 4zlk.1 | 5j03.1 | 5jqa.1 | 5k7l.1 | 5k7l.2 | 5k7l.3 | 5k8q.1 | 5nin.1 | 5nin.2 | 5v02.1 | 5v03.1 | 5v7x.1 | 5vms.1 | 5vms.2 | 5vms.3 | 6b8l.1 | 6b8l.2 | 6b8l.3 | 6b8l.4 | 6b8m.1 | 6b8m.2 | 6b8m.3 | 6b8m.4 | 6b8n.1 | 6b8n.2 | 6b8n.3 | 6b8n.4 | 6b8p.1 | 6b8p.2 | 6b8p.3 | 6b8p.4 | 6b8q.1 | 6b8q.2 | 6b8q.3 | 6b8q.4 | 6cnm.1 | 6cnn.1 | 6cno.1 | 6dmw.1 | 6e2f.1 | 6e2g.1 | 6feg.1 | 6feh.1 | 6ji8.1 | 6jiu.1 | 6jiy.1 | 6jrs.1 | 6jv2.1 | 6k4k.1 | 6k4k.2 | 6k4l.1 | 6k4l.2 | 6k4r.1 | 6k4r.2 | 6mba.1 | 6mc9.1 | 6mud.1 | 6n5w.1 | 6paw.1 | 6paw.2 | 6paw.3 | 6paw.4 | 6pbx.1 | 6pby.1 | 6s5t.1 | 6sz5.1 | 6uzz.1 | 6v00.1 | 6v01.1 | 6xxf.1 | 6y4o.1 | 7b1g.1 | 7bf1.1 | 7bf2.1 | 7byl.1 | 7bym.1 | 7byn.1 | 7cr0.1 | 7cr1.1 | 7cr2.1 | 7cr3.1 | 7cr4.1 | 7cr7.1 | 7kl5.1 | 7sx3.1 | 7sx4.1 | 7tci.1 | 7tcp.1 | 7u9t.1 | 7ua3.1 | 7ua4.1 | 7vnp.1 | 7vnq.1 | 7vnr.1 | 7wji.1 | 7wr4.1 | 7wr5.1 | 7xn4.1 | 7xn5.1 | 7xn6.1 | 8ahs.1 | 8bx7.1 | 8dgh.1 | 8dgk.1 | 8ijk.1 | 8izy.1 | 8j00.1 | 8j01.1 | 8j04.1 | 8j05.1 | 8j07.736 | 8jfk.1 | 8sik.1 | 8sim.1 | 8sin.1 | 8uxl.1 | 8uxm.1 | 8w41.1 | 8x43.1 | 8xya.1 | 8xyb.1 | 9cui.1 | 9cuk.1